No Data
No Data
Solid Earnings May Not Tell The Whole Story For Well Lead Medical (SHSE:603309)
The market for Well Lead Medical Co., Ltd.'s (SHSE:603309) stock was strong after it released a healthy earnings report last week. While the profit numbers were good, our analysis has found some conc
Weili Healthcare (603309): Significant improvement in overseas business and increased profitability
Matters: The company released financial reports. In '23, the company achieved revenue of 1,388 million yuan (+1.79%), net profit to mother of 192 million yuan (+15.56%), deducting non-net profit of 180 million yuan (+23.25%)
Weili Healthcare (603309): Actively explore overseas markets with high dividends to give back to shareholders
Weili Healthcare has released its 2023 annual report. In 2023, the company achieved operating income of 1,388 billion yuan (year-on-year increase of 1.79%); realized net profit of 192 million yuan (year-on-year increase of 15.56%); achieved deductions
Well Lead Medical Co., Ltd. (SHSE:603309) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Well Lead Medical (SHSE:603309) has had a great run on the share market with its stock up by a significant 13% over the last week. But the company's key financial indicators appear to be differing a
Weili Healthcare (603309): 23Q4 performance growth exceeded expectations and accelerated overseas market development
Event: The company released the 2023 annual report and the first quarter report of 2024. The full year of 2023 achieved operating income of 1,388 million yuan (YoY +1.79%) and net profit of 192 million yuan (YoY+1)
Weili Medical (603309): Maintain steady operation and continue to consolidate business
Event Overview The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 1,387 billion yuan, an increase of 1.79% over the previous year; net profit to mother was 192 million yuan, an increase of 15.56% over the previous year;
No Data